ChartRow logo
CORT
Corcept Therapeutics IncorporatedStock · Health Care
$110.58−$1.60 (-1.43%)as of market close, Aug 13, 2026
☾ After hours:$110.51+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

CORT financial statements

The full income statement, balance sheet, and cash-flow statement for Corcept Therapeutics Incorporated (CORT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 104.5M2024-09 104.8M2024-12 105.5M2025-03 106.0M2025-06 105.4M2025-09 105.2M2025-12 106.4M2026-03 107.4M2026-06 108.1M+3.5% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
761M
YoY+12.8%
675M
YoY+39.9%
482M
YoY+20.0%
402M
YoY+9.8%
366M
YoY+3.4%
Cost of revenue
13.0M
YoY+19.3%
10.9M
YoY+67.9%
6.48M
YoY+20.4%
5.38M
YoY+2.0%
5.28M
YoY-5.4%
Research & development
255M
YoY+3.2%
247M
YoY+33.9%
184M
YoY+40.7%
131M
YoY+15.0%
114M
YoY-0.8%
Selling, general & administrative
449M
YoY+60.1%
280M
YoY+52.1%
184M
YoY+20.6%
153M
YoY+24.9%
122M
YoY+16.2%
Amortization of intangibles
465K
YoY-2.5%
477K
YoY+16.6%
409K
Operating income
44.8M
YoY-67.3%
137M
YoY+27.7%
107M
YoY-4.8%
113M
YoY-9.5%
124M
YoY-2.9%
Other non-operating income
21.7M
YoY-11.7%
24.5M
YoY+42.1%
17.3M
YoY+385.7%
3.56M
YoY+572.4%
529K
Pre-tax income
66.5M
YoY-58.8%
161M
YoY+29.7%
125M
YoY+7.2%
116M
YoY-7.1%
125M
YoY-5.0%
Income tax
-33.2M
YoY-263.6%
20.3M
YoY+10.1%
18.4M
YoY+24.7%
14.8M
YoY+18.2%
12.5M
YoY-51.2%
99.7M
YoY-29.4%
141M
YoY+33.0%
106M
YoY+4.7%
101M
YoY-9.9%
113M
YoY+6.1%
$0.82
YoY-33.3%
$1.23
YoY+30.9%
$0.94
YoY+8.0%
$0.87
YoY-2.2%
$0.89
YoY+4.7%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
485M
YoY+2.9%
472M
YoY+2.8%
459M
YoY-8.1%
499M
YoY+87.4%
266M
YoY-44.3%
837M
YoY-0.5%
841M
YoY+35.2%
622M
YoY+6.5%
583M
YoY+37.7%
424M
YoY-25.9%
166M
YoY+18.0%
141M
YoY+34.7%
105M
YoY+44.2%
72.5M
YoY+52.5%
47.5M
YoY+0.1%
189M
YoY+17.3%
161M
YoY+40.2%
115M
YoY+40.7%
81.6M
YoY+70.2%
48.0M
YoY-0.9%
648M
YoY-4.7%
680M
YoY+34.1%
507M
YoY+1.0%
502M
YoY+33.5%
376M
YoY-28.2%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
142M
YoY-28.4%
198M
YoY+56.5%
127M
YoY+5.3%
120M
YoY-28.3%
168M
YoY+10.5%
69.8M
YoY+139.3%
-178M
YoY-295.4%
90.9M
YoY+179.5%
-114M
YoY-184.0%
136M
YoY+214.1%
-220M
YoY-677.3%
-28.3M
YoY+80.9%
-149M
YoY-760.5%
-17.3M
YoY+94.3%
-303M
YoY-2577.4%
FX effect on cash
1.44M
YoY+732.5%
-228K
YoY-163.7%
358K
Net change in cash
-7.17M
YoY+9.1%
-7.89M
YoY-111.4%
69.2M
YoY+713.2%
-11.3M
YoY-891.0%
1.43M
YoY-96.8%
Income taxes paid
13.0M
YoY-78.5%
60.3M
YoY+26.6%
47.6M
YoY+19.8%
39.7M
YoY+336.6%
9.10M
YoY-16.1%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
3.70B
YoY-30.4%
5.32B
YoY+58.8%
3.35B
YoY+53.1%
2.19B
YoY+4.2%
2.10B
YoY-31.6%
P/E
37.1×
YoY-1.3%
37.6×
YoY+2.8%
36.6×
YoY+95.8%
18.7×
YoY+0.3%
18.6×
YoY-35.6%
P/S
4.9×
YoY-38.3%
7.9×
YoY+5.9%
7.4×
YoY+35.3%
5.5×
YoY-4.1%
5.7×
YoY-33.9%
P/B
5.7×
YoY-27.0%
7.8×
YoY+7.9%
7.3×
YoY+57.0%
4.6×
YoY-17.3%
5.6×
YoY-4.8%
P/FCF
26.1×
YoY-3.7%
27.1×
YoY+25.0%
21.7×
YoY+34.8%
16.1×
YoY+28.4%
12.5×
YoY-38.5%
2.7%
YoY+1.3%
2.7%
YoY-2.7%
2.7%
YoY-48.9%
5.3%
YoY-0.3%
5.4%
YoY+55.2%
3.8%
YoY+3.8%
3.7%
YoY-20.0%
4.6%
YoY-25.8%
6.2%
YoY-22.1%
8.0%
YoY+62.5%
Source filing10-K10-K10-K10-K10-K

About this data

Source: CORT's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CORT filings on SEC EDGAR → Not investment advice.